Revisiting the cholinergic hypothesis in the development of Alzheimer's disease

LA Craig, NS Hong, RJ McDonald - Neuroscience & Biobehavioral …, 2011 - Elsevier
Alzheimer's disease (AD) is the most common form of dementia affecting the elderly
population today; however, there is currently no accurate description of the etiology of this …

Neurotrophic factors in Alzheimer's and Parkinson's disease brain

GJ Siegel, NB Chauhan - Brain Research Reviews, 2000 - Elsevier
The biomedical literature on the subject of neurotrophic growth factors has expanded
prodigiously. This essay reviews neurotrophic factors (NTF) and their receptors in …

Neurobiology of the nicotine withdrawal syndrome

PJ Kenny, A Markou - Pharmacology Biochemistry and Behavior, 2001 - Elsevier
The aversive aspects of withdrawal from chronic nicotine exposure are thought to be an
important motivational factor contributing to the maintenance of the tobacco habit in human …

Nicotinic receptors in aging and dementia

MR Picciotto, M Zoli - Journal of neurobiology, 2002 - Wiley Online Library
Activation of neuronal nicotinic acetylcholine receptors (nAChRs) has been shown to
maintain cognitive function following aging or the development of dementia. Nicotine and …

[PDF][PDF] Neuroprotection via nAChRs: the role of nAChRs in neurodegenerative disorders such as Alzheimer's and Parkinson's disease

MR Picciotto, M Zoli - Front Biosci, 2008 - researchgate.net
Introduction 3. Epidemiological studies of smoking and Alzheimer's or Parkinson's disease
4. Expression and function of nicotinic acetylcholine receptors in Parkinson's disease …

Smoking and Parkinson's disease in twins

CM Tanner, SM Goldman, DA Aston, R Ottman… - Neurology, 2002 - AAN Enterprises
Objective: To test the hypothesis that cigarette smoking protects against the development of
PD. Background: Smoking has been inversely associated with PD in many studies, but …

[HTML][HTML] Increased neurodegeneration during ageing in mice lacking high‐affinity nicotine receptors

M Zoli, MR Picciotto, R Ferrari, D Cocchi… - The EMBO …, 1999 - embopress.org
We have examined neuroanatomical, biochemical and endocrine parameters and spatial
learning in mice lacking the β2 subunit of the nicotinic acetylcholine receptor (nAChR) …

Current evidence for neuroprotective effects of nicotine and caffeine against Parkinson's disease

GW Ross, H Petrovitch - Drugs & aging, 2001 - Springer
Parkinson's disease (PD) is the second most common neurodegenerative disorder affecting
1 to 3% of individuals over the age of 65 years. While effective therapy exists for treating the …

Multiple roles for nicotine in Parkinson's disease

M Quik, LZ Huang, N Parameswaran, T Bordia… - Biochemical …, 2009 - Elsevier
There exists a remarkable diversity of neurotransmitter compounds in the striatum, a pivotal
brain region in the pathology of Parkinson's disease, a movement disorder characterized by …

An animal model of adolescent nicotine exposure: effects on gene expression and macromolecular constituents in rat brain regions

JA Trauth, FJ Seidler, TA Slotkin - Brain research, 2000 - Elsevier
Nearly all smokers begin tobacco use in adolescence, and approximately 25% of US
teenagers are daily smokers. Prenatal nicotine exposure is known to produce brain damage …